Acar C, Sözen MM, Gözükara H, Orman K, Kartalcı Ş (2015) Lack of association between catechol-Omethyltransferase and schizophrenia in a Turkish population. Turk J Biochem 40:205–209
Google Scholar
Camkurt MA, Karababa F, Erdal ME, Bayazıt H, Kandemir SB, Ay ME, Kandemir H, Ay Öİ, Çiçek E, Selek S, Taşdelen B (2016) Investigation of dysregulation of several microRNAs in peripheral blood of schizophrenia patients. Clin Psychopharmacol Neurosci 14:256
Article
CAS
PubMed
PubMed Central
Google Scholar
Chaychi I, Foroughipour M, Haghir H, Talaei A, Chaichi A (2015) Electroencephalographic characteristics of Iranian schizophrenia patients. Acta Neurol Belg 115:665–670
Article
PubMed
Google Scholar
Chowdari KV, Bamne M, Wood J, Talkowski ME, Mirnics K, Levitt P, Lewis DA, Nimgaonkar VL (2008) Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia. Schizophr Bull 34:118–126
Article
PubMed
Google Scholar
Cui D, Jiang K (2012) Research in China on the molecular genetics of schizophrenia. Shanghai Arch Psychiatry 24:187
CAS
PubMed
PubMed Central
Google Scholar
Ding L, Styblo M, Drobná Z, Hegde AN (2016) Expression of the longest RGS4 splice variant in the prefrontal cortex is associated with single nucleotide polymorphisms in schizophrenia patients. Front Psychiatry 7:26
Article
PubMed
PubMed Central
Google Scholar
Dwivedi Y (2017) microRNA-124: a putative therapeutic target and biomarker for major depression. Taylor & Francis, Routledge
Google Scholar
Estrada G, Fatjo-Vilas M, Munoz MJ, Pulido G, Minano MJ, Toledo E, Illa JM, Martin M, Miralles ML, Miret S, Campanera S, Bernabeu C, Navarro ME, Fananas L (2011) Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatry Scand 123:485–492
Article
CAS
Google Scholar
Funahashi Y, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Mori T, Ochi S, Iga JI, Ueno SI (2019) Analysis of methylation and-141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia. Psychiatry Res 278:135–140
Article
CAS
PubMed
Google Scholar
Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, DeRosse P, Kane JM, Kucherlapati R (2005) COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1:19
Article
PubMed
PubMed Central
Google Scholar
George TP, Thomas T (2016) Novel approach to analyzing MFE of noncoding RNA sequences. Genomics Insights 9:41–49
Article
PubMed
PubMed Central
Google Scholar
Ghanbari Jolfaei A, Moshki P, Asgharpour M, Moshki H (2012) The Relationship between attention/vigilance and symptom severity in schizophrenic patients. Iran J Psychiatr 7:22–25
Google Scholar
Gong Y, Wu CN, Xu J, Feng G, Xing QH, Fu W, Li C, He L, Zhao XZ (2013) Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets. Eur Neuropsychopharmacol 23:1182–1189
Article
CAS
PubMed
Google Scholar
Gonzalez-Castro TB, Hernandez-Diaz Y, Juarez-Rojop IE, Lopez-Narvaez ML, Tovilla-Zarate CA, Genis-Mendoza A, Alpuin-Reyes M (2016) The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis. Behav Brain Funct 12:29
Article
PubMed
PubMed Central
Google Scholar
Gozukara Bag HG (2018) Association between COMT gene rs165599 SNP and schizophrenia: a meta-analysis of case-control studies. Mol Genet Genomic Med 6:845–854
Article
CAS
PubMed
PubMed Central
Google Scholar
Grace AA (2016) Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17:524
Article
CAS
PubMed
PubMed Central
Google Scholar
Hatami M, Karamghadiri N, Mohaghegh H, Yoosefee S, Karimipoor M, Hadjighasem M, Ananloo ES (2017) Neuregulin-1 gene and schizophrenia, and its negative symptoms in an iranian population. Iran J Psychiatry Behav Sci 11:e4484
Google Scholar
Kay SR, Opler LA, Lindenmayer JP (1988) Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23:99–110
Article
CAS
PubMed
Google Scholar
Kesby JP, Eyles DW, McGrath JJ, Scott JG (2018) Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry 8:1–12
Article
Google Scholar
Kuncara DB (2019) Polymorphism of Dopamine D2–141C Ins/Del receptor gene in paranoid schizophrenia and non schizophrenia patients of batak ethnicity in sumatera utara. Bul Farmatera 4:18–28
Article
Google Scholar
Ledonne A, Nobili A, Latagliata EC, Cavallucci V, Guatteo E, Puglisi-Allegra S, D’Amelio M, Mercuri NB (2015) Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol Psychiatry 20:959–973
Article
CAS
PubMed
Google Scholar
Liu L, Fan D, Ding N, Hu Y, Cai G, Wang L, Xin L, Xia Q, Li X, Xu S, Xu J (2014) The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis. Neurosci Lett 583:43–48
Article
CAS
PubMed
Google Scholar
Lorenz R, Bernhart SH, Höner zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6:26
Article
PubMed
PubMed Central
Google Scholar
Luykx JJ, Broersen JL, de Leeuw M (2017) The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: a systematic review and meta-analysis. Neurosci Biobeh Rev 74:214–224
Article
CAS
Google Scholar
Morozova A, Zorkina Y, Pavlov K, Pavlova O, Storozheva Z, Zubkov E, Zakharova N, Karpenko O, Reznik A, Chekhonin V, Kostyuk G (2019) Association of rs4680 COMT, rs6280 DRD3 and rs7322347 5HT2A with clinical features of youth-onset schizophrenia. Front Psychiatry 10:830
Article
PubMed
PubMed Central
Google Scholar
Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T (2007) No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neurosci Res 58:291–296
Article
CAS
PubMed
Google Scholar
O’Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (lausanne) 9:402
Article
CAS
Google Scholar
Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, Kitajima T, Yamanouchi Y, Tomita M, Inada T, Ozaki N, Iwata N (2009) Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 110:140–148
Article
PubMed
Google Scholar
Paspalas CD, Selemon LD, Arnsten AFT (2009) Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb Cortex 19:2145–2155
Article
PubMed
PubMed Central
Google Scholar
Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M, Singha RS, Malakar AK, Chakraborty S (2018) Interplay between miRNAs and human diseases. J Cell Physiol 233:2007–2018
Article
CAS
PubMed
Google Scholar
Paul S, Reyes PR, Garza BS, Sharma A (2019) MicroRNAs and child neuropsychiatric disorders: a brief review. Neurochem Res 45:232–240
Article
PubMed
Google Scholar
Poorshekar S, Firoozfar A, Yassini Ardekani SM, Kalantar SM (2019) Study of the association between DRD2 Gene Ser311Cys and GSTM1 gene polymorphism in schizophrenia. SSU J 27:1602–1611
Google Scholar
Qi J, David M (2012) MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med 6:134–155
Article
PubMed
PubMed Central
Google Scholar
Raznahan A, Greenstein D, Lee Y, Long R, Clasen L, Gochman P, Addington A, Giedd JN, Rapoport JL, Gogtay N (2011) Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls. Neuroimage 57:1517–1523
Article
CAS
PubMed
Google Scholar
Risch N (1990) Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 46:242–253
CAS
PubMed
PubMed Central
Google Scholar
Schwarz E (2018) A gene-based review of RGS4 as a putative risk gene for psychiatric illness. Am J Med Genet Part B Neuropsychiatr Genet 177:267–273
Article
Google Scholar
Shariati SA, Behmanesh M, Galehdari H (2011) A study of the association between SNP8NRG241930 in the 5′End of Neuroglin 1 gene with schizophrenia in a group of Iranian patients. Cell J (yakhteh) 13:91
CAS
Google Scholar
Shi S, Leites C, He D, Schwartz D, Moy W, Shi J, Duan J (2014) MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. J Biol Chem 289:13434–13444
Article
CAS
PubMed
PubMed Central
Google Scholar
Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296–1302
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh J, Kour K, Jayaram MB (2012) Acetylcholinesterase inhibitors for schizophrenia. Cochrane Database Syst Rev 1:CD007967
PubMed
Google Scholar
Taylor S (2018) Association between COMT Val158Met and psychiatric disorders: a comprehensive meta-analysis. Am J Med Genet B Neuropsychiatr Genet 177:199–210
Article
CAS
PubMed
Google Scholar
Williams HJ, Glaser B, Williams NM, Norton N, Zammit S, MacGregor S, Kirov GK, Owen MJ, O’Donovan MC (2005) No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 162:1736–1738
Article
PubMed
Google Scholar
Yu H, Yan H, Wang L, Li J, Tan L, Deng W, Chen Q, Yang G, Zhang F, Lu T, Yang J, Li K, Lv L, Tan Q, Zhang H, Xiao X, Li M, Ma X, Yang F, Li L, Wang C, Li T, Zhang D, Yue W, Consortium Chinese Antipsychotics Pharmacogenomics (2018) Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. Lancet Psychiatry 5:327–338
Article
PubMed
Google Scholar
Zhang HX, Zhao JP, Lv LX, Li WQ, Xu L, Ouyang X, Yuan ZQ, Huang JS (2008) Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia. Neurosci Lett 438:1–5
Article
CAS
PubMed
Google Scholar
Zhang Y, Wang Y, Wang L, Bai M, Zhang X, Zhu X (2015) Dopamine receptor D2 and associated microRNAs are involved in stress susceptibility and resistance to escitalopram treatment. Int J Neuropsychopharmacol 18:pyv025
Article
PubMed
PubMed Central
Google Scholar